8
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Nalbuphine Hydrochloride Dependence in Anabolic Steroid Users

Pages 161-164 | Published online: 10 Jul 2009

  • Preston KI. Bigelow CE. Drug discriminalion assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphonebutorphanol procedure. J Pharmacol Exp Ther.1994: 271:48-60.
  • Brainum I. Antonio I. Street C. Reality check on Nubain. FLEX, June, 1997:137-138.
  • Western Daily Press. June 21. 1994. Cited by: McBriile A.I. Williamson K. Petersen T. Three cases of nalbuphine hydrochloride dependence associated with anabolic steriod use. Br J Sports Med.1996;30:69-70.
  • McBride A.I. Williamson K. Petersen T. Three cases of nalbuphine hydrochloride dependence associated with analbolic steroid use. Br J Sports Med. 1996. 30:69-70.
  • Gruber A J., Pope HG. Ephedrine abuse among 36 female weightlifters. Am J Addict. 1998;7:256-261
  • Pope HG, Gruber AJ, Choi p, et al. Muscle dysmor-phia: an underrecognized form of body dysmorphic disorder. Psychosomatics. 1997:38:548-557.
  • Brown GR. Stadol dependence another case [let-ter]. JAMA. 1985;254:910.
  • Evans WS. Bowen J.N. Giordan FL. et al. A case of Stadol dependence [letter]. JAMA, 1985;253:2191-2192.
  • Lukas SK. Brady JV. Griffiths RR. Comparison of opioid self-injection and disruption of schedulecontrolled performance in the baboon. J Pharmacol Exp Ther 1986;238:924-931.
  • Jasinski DR. Mansky PA. Evaluation of nalbuphine for abuse potential. Clin Pharmacol Ther. 1972;13:78-90.
  • Brady JV, Lukas SE. eds. Testing drugs for physical dependence potential and abuse liability. NIDAResearch Monograph 52;198i.
  • Yesalis CK. Kennedy NJ. Kopstein AN. et al. Anabolic-androgenic steroid use in the United States. JAMA. 1993;270:1217-1221.
  • Lukas SE. Current perspectives on anabolic- androgenic steroid abuse. Trends Pharmacol Sci. 1993;14::61-68.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.